Your session is about to expire
← Back to Search
Pioglitazone + Weight Loss for Kidney Stones
Study Summary
This trial will compare the effects of a weight loss program with or without the drug Pio on obese people with type 2 diabetes.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My kidney stones are mostly made of uric acid.I have chronic diarrhea.Your HbA1c level is higher than 8.5%.I frequently get urinary tract infections.I am currently using insulin.I have not taken thiazolidinedione drugs in the last 2 years.I have had weight loss surgery.I cannot use certain diabetes medications due to liver disease, swelling in my legs, severe heart failure, or not using birth control.I have bladder cancer.I am currently taking medications like SGLT2 inhibitors or GLP-1 analogs.I am older than 21 years.Your kidney function is normal.I weigh less than 165 Kg.
- Group 1: Pioglitazone Drug (including Placebo)
- Group 2: Weight Loss, Behavioral
- Group 3: Pioglitazone + Weight Loss
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has there been any previous research on utilizing Weight Loss as a therapeutic intervention?
"Currently, 31 medical studies involving Weight loss are still ongoing with 4 of them in the advanced Phase 3. These trials can found at 69 distinct sites around the world, including Lausanne, Vaud."
Is the efficacy of weight loss interventions endorsed by the FDA?
"As this is a phase 4 trial, indicating that the treatment has already been approved for use in clinical settings, the safety score of weight loss was rated with a 3."
Is there any availability for enrolment in this experiment?
"That is correct. According to the information on clinicaltrials.gov, this research project commenced recruiting participants on October 17th 2019 and has most recently been updated on May 19th 2022. This trial requires 54 volunteers from one site to participate in the study."
Are there any criteria for selecting participants for this clinical investigation?
"This medical trial can accept 54 applicants, provided they have elevated uric acid and are between 21-99 years of age."
How has Weight Loss been demonstrated to be beneficial in treating medical conditions?
"Weight loss is frequently prescribed to manage diabetes, as well as other ailments like diabetic neuralgia and lifestyle modifications."
Are participants aged over 30 eligible for this trial?
"To be considered for this medical trial, participants must have ages ranging from 21 to 99. There are 25 studies available for those younger than 18 and 273 specifically tailored towards elderly patients."
How many individuals are taking part in this experiment?
"Indeed, according to clinicaltrials.gov, this experiment is presently recruiting participants. Its initial posting was on October 17th 2019 with the latest update being May 19th 2022; 54 people are sought for enrolment at a single location."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger